Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment

Žan Toplak(University of Ljubljana), Luis A. Pardo(Max Planck Society)
Medicinal Research Reviews
May 4, 2021
Cited by 40


Related Papers